Immunopathological evaluation of recombinant mycobacterial antigen Hsp65 expressed in Lactococcus lactis as a novel vaccine candidate.

Bovine tuberculosis (TBB) is a zoonotic disease distributed worldwide and is of great importance for public health and the livestock industry. Several experimental vaccines against this disease have been evaluated in recent years, yielding varying results. An example is the Bacillus Calmette-Guérin (BCG) vaccine, which has been used extensively in humans and tested in cattle showing mixed results related to protection (0-80%) against Mycobacterium bovis. In this study, we used the food-grade bacterium Lactococcus lactis as an expression system for production of mycobacterial protein Hsp65. For this purpose, the construction of a replicable plasmid in strain NZ9000 L. lactis (pVElepr) was conducted, which expressed the Mycobacterium leprae Hsp65 antigen, and was recognized by traded anti-Hsp65 antibodies. The strain NZ9000-pVElepr was applied to calves that were negative to tuberculin test and the immune response was monitored. The results showed that immune response was not significantly increased in calves with NZ9000-pVElepr with respect to control groups, and no injury was observed in any lung or lymph of the calves. Finally, this study suggest that the recombinant NZ9000 strain of L. lactis may protect against the development of M. bovis infection, although studies with longer exposure to this pathogen are necessary to conclude the matter.

Field evaluation of the protective efficacy of Mycobacterium bovis BCG vaccine against bovine tuberculosis.

The protective efficacy of Mycobacterium bovis BCG (1 x 10(6) single dose) was evaluated under field conditions. A total of 140 male Holstein Friesian calves, one to two week-old were selected. Two groups of 70 each were formed, one group was vaccinated and the other was injected with a placebo during their second week of age and followed until 12 months of age. The study considered a positive case of tuberculosis to be an animal that had a positive reaction to the three following tests in a row: tuberculin, IFNgamma PPD-B and IFNgamma ESAT6-CFP10 during the 12 months of exposure. The results showed a 59.4% efficacy (IC95%: 47.64-71.16). The non-vaccinated calves were 2.4 times more at risk of becoming infected (IC95%: 1.07-5.68) compared to vaccinated animals. As a complementary test a PCR test was performed using nasal exudates in some animals from both groups using a Mycobacterium complex detection kit. All the positive PCR reactions (5/44) were found in the non-vaccinated animals. These findings suggest that the use of the BCG vaccine, even though it is not capable of protecting 100%, does prevent TB vaccinated animals from excreting bacilli in their nasal secretions at their first year of age.

Searching for Lyme disease in Colombia: a preliminary study on the vector.

Lyme disease is an infectious multisystemic illness with dermatologic, neurologic, cardiac, and rheumatic manifestations. A total of 4,355 ticks was collected in Colombia, of which 2,805 were identified as Ixodes spp. The midgut contents of 2,600 specimens were fixed on microscope slides and examined by an indirect immunofluorescence assay (IFA) using monoclonal antibodies, anti-ospA H5332, and anti-flagellin 9724. All of the ticks examined by IFA tested negative.

An abattoir monitoring system for diagnosis of tuberculosis in cattle in Baja California, Mexico.

OBJECTIVE: To implement a disease monitoring system in federal, municipal, and private abattoirs in Baja California, Mexico and to estimate annual prevalence of tuberculosis (TB) in beef and dairy cattle slaughtered and inspected in 1995 and 1996. DESIGN: Epidemiologic survey. ANIMALS: About 200,000 cattle (95% beef, 5% dairy). PROCEDURES: Lymph node and tissue specimens with lesions suggestive of TB were fixed in neutral-buffered 10% formalin and embedded in paraffin. Sections were stained with H&E and Ziehl-Neelsen and examined for typical tuberculous lesions and acid-fast bacilli. Annual prevalence and 95% confidence intervals were estimated. RESULTS: Prevalence of TB in all slaughtered cattle was 0.12 and 0.46% in 1995 and 1996, respectively (beef cattle, 0.02 and 0.05%, respectively; dairy cattle, 2.0 and 8.3%, respectively). Tuberculosis cases/1,000 slaughtered cattle were linearly associated with monthly volumes of tissue submissions. CLINICAL IMPLICATIONS: It is critical to quantify the monitoring activity at abattoirs to better estimate the prevalence of TB in slaughtered cattle. Annual prevalence of TB was significantly greater in dairy cattle than in beef cattle. Veterinarians and cattle producers in this region are encouraged to develop and work on herd plans aimed at controlling and eradicating TB.